Filana Gains FDA Lift of Simufilam Clinical Hold
AUSTIN, Texas — September 22, 2026 Filana Therapeutics announced that the U.S. Food and Drug Administration has lifted the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
AUSTIN, Texas — September 22, 2026 Filana Therapeutics announced that the U.S. Food and Drug Administration has lifted the...
VANCOUVER, Canada — September 17, 2026 Clearmind Medicine announced that its Chief of Global Impact, Mary-Elizabeth Gifford, testified at...
NEW HAVEN, Conn., July 27, 2026 Biohaven Ltd. and Yale University have secured a significant legal victory after a...
